What is the significance of a ferritin level of 719 ng/mL and what diagnostic workup and management should be pursued?

Elevated Ferritin of 719 ng/mL: Diagnostic Workup and Management

A ferritin level of 719 ng/mL requires immediate measurement of transferrin saturation (TS) to distinguish between hereditary hemochromatosis and secondary causes of elevated ferritin, as this level falls below the critical 1000 µg/L threshold that predicts cirrhosis but is significantly elevated and demands investigation. 1

Initial Diagnostic Approach

The first critical step is to measure fasting transferrin saturation alongside the ferritin 1. This combination provides substantially better diagnostic accuracy than ferritin alone, as ferritin is an acute-phase reactant that elevates with inflammation, infection, malignancy, liver disease, and metabolic syndrome—not just iron overload 2, 3.

Key Diagnostic Thresholds

• If TS ≥45%: Proceed immediately to HFE genetic testing (C282Y and H63D mutations) 1
• If TS <45%: Consider secondary causes of hyperferritinemia rather than primary iron overload

Risk Stratification Based on Ferritin Level

At 719 ng/mL, this patient sits in a critical zone:

• Ferritin <1000 µg/L with normal liver enzymes (ALT, AST): Accurately predicts absence of cirrhosis 1
• Ferritin >1000 µg/L with elevated ALT/AST and platelets <200: Predicts cirrhosis in 80% of C282Y homozygotes 1

Therefore, check ALT, AST, and platelet count immediately to assess liver disease risk 1.

Genetic Testing Interpretation and Next Steps

If C282Y Homozygote Confirmed:

Proceed directly to therapeutic phlebotomy without liver biopsy since ferritin is <1000 µg/L and assuming normal liver enzymes 1. This is a strong 1B recommendation from AASLD guidelines.

• Target ferritin: 50-100 µg/L 1
• Phlebotomy frequency: Weekly as tolerated during induction phase 1
• Monitor: Check ferritin every 10-12 phlebotomies 1

If Compound Heterozygote (C282Y/H63D) or Non-HFE Genotype:

Liver biopsy or MRI for hepatic iron concentration (HIC) is required to confirm iron overload 1. The 2022 EASL guidelines 4 recommend MRI as first-line for assessing hepatic iron content in these cases.

If Ferritin >1000 µg/L or Elevated Liver Enzymes Present:

Liver biopsy is indicated to assess for cirrhosis and stage fibrosis, regardless of genotype 1, 5, 1. Patients with advanced fibrosis require hepatocellular carcinoma surveillance.

Secondary Causes to Exclude

Since ferritin is an acute-phase reactant, evaluate for 1, 2:

• Inflammatory conditions: Check CRP, ESR
• Liver disease: Chronic hepatitis B/C, NAFLD, alcoholic liver disease
• Malignancy: Lymphoma, other cancers
• Chronic kidney disease: Check creatinine, eGFR
• Metabolic syndrome: Assess for diabetes, obesity, dyslipidemia

In inflammatory conditions, ferritin can be elevated despite functional iron deficiency due to hepcidin-mediated iron sequestration 3. In these cases, TS <20% suggests true iron restriction despite elevated ferritin.

Common Pitfalls to Avoid

1. Do not rely on ferritin alone: Always pair with transferrin saturation 1
2. Do not assume iron overload: Ferritin 719 ng/mL can be entirely from inflammation without any iron overload 2
3. Do not delay genetic testing: If TS ≥45%, HFE testing should be immediate 1
4. Do not perform unnecessary liver biopsy: C282Y homozygotes with ferritin <1000 µg/L and normal liver enzymes can proceed directly to phlebotomy 1

Treatment Considerations

If hereditary hemochromatosis is confirmed:

• Weekly phlebotomy (removing 500 mL blood = 250 mg iron) until ferritin reaches 50-100 µg/L 1
• Avoid vitamin C supplements (increases iron absorption) 1
• Avoid raw shellfish (Vibrio vulnificus risk in iron overload) 1
• No dietary iron restriction needed during treatment 1
• Screen first-degree relatives with both HFE genotyping and iron studies 1

If secondary iron overload from other causes:

• Phlebotomy may benefit NAFLD (improves insulin resistance, reduces ALT) 1
• Not recommended for mild secondary overload in chronic hepatitis C 1
• Iron chelation (deferoxamine or deferasirox) reserved for transfusion-dependent anemias 1

Algorithmic Summary

1. Measure TS immediately (fasting preferred but not mandatory per 2011 update) 1
2. Check ALT, AST, platelets for liver disease assessment 1
3. If TS ≥45% → HFE genetic testing 1
4. If C282Y homozygote + ferritin <1000 + normal liver enzymes → Start phlebotomy without biopsy 1
5. If other genotype or elevated liver enzymes → Liver biopsy or MRI for HIC 1, 4
6. If TS <45% → Investigate secondary causes (inflammation, liver disease, malignancy) 2